Gilead announces positive Biktarvy data for HIV and hepatitis B
|
Biktarvy
is a complete HIV treatment, combining three medicines to form the
smallest three-drug, single-tablet regimen (STR) available, as a
simple ... |
FDA slaps clinical hold on multiple Gilead HIV trials
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns. View article...